Pharmacosmos CRO A/S
Contract Research Organisation / Clinical Development
Description
Pharmacosmos CRO is a development CRO supporting the development needs of European biotech and pharma companies by offering access to optimised, global development services. The CRO is a spin-off from Pharmacosmos, a Danish-based specialty pharma company with products in over 50 countries globally. Pharmacosmos has established an efficient development model based on an internal core group of development experts supported by a global partner network, which has resulted in faster and more efficient development. This proven development model is now being offered through Pharmacosmos CRO.
Contract Services
- Clinical Development
We offer unique access to optimized global medical product development from the first clinical consideration to marketing of final drug for European biotech and pharmaceutical companies: • Integrated development planning through a senior development team • Patient recruitment in key global geographies through validated partners • Flexibility and agility of an SME • Global regulatory track record • Single point of contact
Read more about - Clinical Development
Service relevant for:
Phase I
Phase IIA
Phase IIB
Phase III
Phase IIIB
Registration
Phase IV studies
Regulatory services
Safety surveillance
Marketing
Clinical Data Management and Biostatistics
Pharmacosmos CRO offer global, cost-efficient Clinical Data Management and Biostatistics services of the highest quality through our Indian partner.
Read more about Clinical Data Management and Biostatistics
Service relevant for:
Phase I
Phase IIA
Phase IIB
Phase III
Phase IIIB
Registration
Phase IV studies
Regulatory services
Safety surveillance
Marketing
Register your organisation
